Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| A M R CP | AAMRQ | 10.54% |
| P L C SYSTEM | PLCSF | 9.19% |
| HUTCHINSON T | HTCH | 6.31% |
| USANA HEALTH | USNA | 6.20% |
| KRATOS DEFEN | KTOS | 5.65% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
In an effort to expand its convenience store chain business, Fomento Economico Mexicano SAB de CV ( FMX - Analyst Report ) or FEMSA announced that its retail subsidiary – FEMSA Comercio – has acquired Farmacias FM Moderna on Monday. Farmacias FM Moderna is a leading drugstore operator in the western state of Sinaloa, Mexico and currently operates over 100 stores in the region. Details about the transaction have not been provided by the company.
The owner of Coca-Cola FEMSA ( KOF - Snapshot Report ) , which is the world’s largest franchise bottler of The Coca-Cola Company ( KO - Analyst Report ) products, is taking prudent steps to diversify its product portfolio while expanding its convenience store chain, which augurs well for future operating performance.
This Zacks Rank #3 (Hold) company is aggressively seeking to capitalize on the growing opportunities for the drugstore business in Mexico. Earlier this month, the company acquired a 75% stake in a leading drugstore operator in Southeast Mexico – Farmacias YZA. We believe that the company’s foray into the drugstore business strategically fits its store chain business, which will be accretive to its top and bottom lines in the long term.
FEMSA, which competes with Coca-Cola Enterprises Inc. ( CCE - Analyst Report ) , has a healthy balance sheet with cash and cash equivalents of Ps. 28.855 billion ($2.336 billion) at the end of first-quarter fiscal 2013. This huge cash balance was primarily an outcome of the sale of its beer business to Heineken NV in 2010 in exchange for a 20% stake in Heineken.
We believe that FEMSA is aptly utilizing its available funds to focus on the core bottling and convenience store operations as well as to implement organic and inorganic expansion plans. In the first quarter of fiscal 2013, FEMSA incurred capital expenditure of Ps.3.213 billion ($0.260 billion), mainly toward incremental investments at Coca-Cola FEMSA to increase the capacity in Columbia.
Read the full reports :
Analyst Report on FMX
Analyst Report on CCE
Analyst Report on KO
Snapshot Report on KOF